Burkitt Lymphoma - Subtypes, Pathogenesis, and Treatment Strategies.


Journal

Clinical lymphoma, myeloma & leukemia
ISSN: 2152-2669
Titre abrégé: Clin Lymphoma Myeloma Leuk
Pays: United States
ID NLM: 101525386

Informations de publication

Date de publication:
09 2020
Historique:
entrez: 1 9 2020
pubmed: 31 8 2020
medline: 24 12 2021
Statut: ppublish

Résumé

Burkitt's lymphoma (BL) is a rare and highly aggressive Non-Hodgkin lymphoma (NHL) with a germinal center phenotype, a nearly universal myc oncogene translocation to an enhancer element and a proliferation index greater than 95%.

Identifiants

pubmed: 32862862
pii: S2152-2650(20)30455-9
doi: 10.1016/S2152-2650(20)30455-9
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

S37-S38

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Ariela Noy (A)

Memorial Sloan Kettering Cancer and Weill Cornell Medical College, New York, NY, USA. Electronic address: noya@MSKCC.ORG.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH